These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1872803)

  • 1. Deletion of two growth-factor repeats from the low-density-lipoprotein receptor accelerates its degradation.
    van der Westhuyzen DR; Stein ML; Henderson HE; Marais AD; Fourie AM; Coetzee GA
    Biochem J; 1991 Aug; 277 ( Pt 3)(Pt 3):677-82. PubMed ID: 1872803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New type of the internalization-defective low-density lipoprotein receptor owing to two-nucleotide deletion (2199delCA or 2201delCA) in Japanese patients with familial hypercholesterolaemia.
    Tashiro J; Endo M; Bujo H; Shinomiya M; Morisaki N; Saito Y
    Eur J Clin Invest; 1998 Sep; 28(9):712-9. PubMed ID: 9767370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of exon encoding cysteine-rich repeat of low density lipoprotein receptor alters its binding specificity in a subject with familial hypercholesterolemia.
    Hobbs HH; Brown MS; Goldstein JL; Russell DW
    J Biol Chem; 1986 Oct; 261(28):13114-20. PubMed ID: 3020025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of a recycling-impaired mutant of low density lipoprotein receptor in familial hypercholesterolemia.
    Miyake Y; Tajima S; Funahashi T; Yamamoto A
    J Biol Chem; 1989 Oct; 264(28):16584-90. PubMed ID: 2777800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion in the first cysteine-rich repeat of low density lipoprotein receptor impairs its transport but not lipoprotein binding in fibroblasts from a subject with familial hypercholesterolemia.
    Leitersdorf E; Hobbs HH; Fourie AM; Jacobs M; van der Westhuyzen DR; Coetzee GA
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):7912-6. PubMed ID: 3263645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpected consequences of deletion of the first two repeats of the ligand-binding domain from the low density lipoprotein receptor. Evidence from a human mutation.
    Sass C; Giroux LM; Lussier-Cacan S; Davignon J; Minnich A
    J Biol Chem; 1995 Oct; 270(42):25166-71. PubMed ID: 7559651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial duplication of the EGF precursor homology domain of the LDL-receptor protein causing familial hypercholesterolemia (FH-Salerno).
    Bertolini S; Patel DD; Coviello DA; Lelli N; Ghisellini M; Tiozzo R; Masturzo P; Elicio N; Knight BL; Calandra S
    J Lipid Res; 1994 Aug; 35(8):1422-30. PubMed ID: 7989866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic consequences of a deletion of exons 2 and 3 of the LDL receptor gene.
    Rødningen OK; Tonstad S; Medh JD; Chappell DA; Ose L; Leren TP
    J Lipid Res; 1999 Feb; 40(2):213-20. PubMed ID: 9925649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of the ligand binding domain of the low density lipoprotein receptor.
    Esser V; Limbird LE; Brown MS; Goldstein JL; Russell DW
    J Biol Chem; 1988 Sep; 263(26):13282-90. PubMed ID: 3417658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid-dependent ligand dissociation and recycling of LDL receptor mediated by growth factor homology region.
    Davis CG; Goldstein JL; Südhof TC; Anderson RG; Russell DW; Brown MS
    Nature; 1987 Apr 23-29; 326(6115):760-5. PubMed ID: 3494949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a point mutation in growth factor repeat C of the low density lipoprotein-receptor gene in a patient with homozygous familial hypercholesterolemia that affects ligand binding and intracellular movement of receptors.
    Soutar AK; Knight BL; Patel DD
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4166-70. PubMed ID: 2726768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-density lipoprotein receptor point mutation results in expression of both active and inactive surface forms of the same mutant receptor.
    Fourie AM; Coetzee GA; Gevers W; van der Westhuyzen DR
    Biochemistry; 1992 Dec; 31(51):12754-9. PubMed ID: 1463746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FH-Freiburg: a novel missense mutation (C317Y) in growth factor repeat A of the low density lipoprotein receptor gene in a German patient with homozygous familial hypercholesterolemia.
    Nauck MS; Scharnagl H; Nissen H; Schürmann C; Matern D; Nauck MA; Wieland H; März W
    Atherosclerosis; 2000 Aug; 151(2):525-34. PubMed ID: 10924730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity.
    Takahashi S; Kawarabayasi Y; Nakai T; Sakai J; Yamamoto T
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9252-6. PubMed ID: 1384047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel low-density lipoprotein receptor-related protein mediating cellular uptake of apolipoprotein E-enriched beta-VLDL in vitro.
    Sugiyama T; Kumagai H; Morikawa Y; Wada Y; Sugiyama A; Yasuda K; Yokoi N; Tamura S; Kojima T; Nosaka T; Senba E; Kimura S; Kadowaki T; Kodama T; Kitamura T
    Biochemistry; 2000 Dec; 39(51):15817-25. PubMed ID: 11123907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and properties of the proline664-leucine mutant LDL receptor in South Africans of Indian origin.
    Rubinsztein DC; Coetzee GA; Marais AD; Leitersdorf E; Seftel HC; van der Westhuyzen DR
    J Lipid Res; 1992 Nov; 33(11):1647-55. PubMed ID: 1464748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replacement of cysteine at position 46 in the first cysteine-rich repeat of the LDL receptor impairs apolipoprotein recognition.
    Benito-Vicente A; Uribe KB; Siddiqi H; Jebari S; Galicia-Garcia U; Larrea-Sebal A; Cenarro A; Stef M; Ostolaza H; Civeira F; Palacios L; Martin C
    PLoS One; 2018; 13(10):e0204771. PubMed ID: 30332439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-density lipoprotein receptor mutation that deletes exons 2 and 3 by Alu-Alu recombination.
    Kigawa K; Kihara K; Miyake Y; Tajima S; Funahashi T; Yamamura T; Yamamoto A
    J Biochem; 1993 Mar; 113(3):372-6. PubMed ID: 8486609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).
    Chappell DA
    J Clin Invest; 1989 Dec; 84(6):1906-15. PubMed ID: 2556448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100.
    Boren J; Lee I; Zhu W; Arnold K; Taylor S; Innerarity TL
    J Clin Invest; 1998 Mar; 101(5):1084-93. PubMed ID: 9486979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.